ZTS in Stage 4 Decline with Faulty 51.4% Deep Base and Bearish Trend

Posted on by Eben@CANSLIM Research
ZTS stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 4 (Declining), as of November 02, 2026 at 01:53 — CANSLIM Research
ZTS is trading at 79.72 in a confirmed Stage 4 downtrend, sitting below a declining 30-week moving average and roughly 43.5% off its 52-week high. The market focus is on a faulty deep base of 51.4% depth built over 50 weeks, with no VCP contraction and only one of eight trend-template checks passing. Overall sentiment is bearish and defensive, with elevated base-failure risk.

ZTS   Daily · data to 2026-10-30 close · 20 SMA 50 SMA 150 SMA
Frozen at publication – this chart does not move. Open live chart on TradingView →

SECTORHealthcareINDUSTRYDrug Manufacturers – Specialty & GenericStage 4Weinstein stage
Data to US close: Fri 30 Oct 16:00 ET = Sat 31 Oct 04:00 HKTCreated: Mon 02 Nov 01:53 HKT = 12:53 ET

Inside the Full Report

  • 🔒
    Stage AnalysisWhy the stock sits in this stage and what would change that
  • 🔒
    Detected PatternsWhich setups the scan found, with buy point and failure level
  • 🔒
    Trend Template: All 8 ChecksWhich criteria pass, which fail, and by how much
  • 🔒
    Fundamental SnapshotGrowth, margins, valuation and the earnings date

Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Figures come from the scanned result (as of November 02, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.

Continue Reading

This article is for pass holders.

Already a pass holder? Sign in · Continue with Google

Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Related Posts